Latest Gamma-Hydroxybutyric acid Stories
Trial Initiated in Response to a FDA Pediatric Written Request to Study Xyrem in Children and Adolescents DUBLIN, Dec.
Study Demonstrated Robust Alerting Effect Consistent with Phase 2a Results DUBLIN, June 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b
Phase 2b Data for JZP-110 in Adults with EDS in Narcolepsy Accepted as Late-Breaker Oral Presentation DUBLIN, May 27, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced
Best Drug Rehabilitation, which offers treatment programs and believes that having family close by during a stay in rehab can make a big difference in whether or not the process is successful,
New Model May Also Explain How Narcolepsy Develops in Humans MENLO PARK, Calif., May 7, 2014 /PRNewswire/ -- Neuroscientists at SRI International have found that a form of baclofen,
A team of researchers from the National University of Singapore (NUS) has developed the world's first fluorescent sensor to identify the presence of a drug known as GHB that is commonly used to spike beverages.
Terms include $125 million upfront payment in cash plus a potential of up to $272 million in milestone payments DUBLIN, Jan.
DUBLIN, Jan. 6, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 32(nd) Annual J.P.
- a slit in a tire to drain away surface water and improve traction.